Series B Investors & VC Firms in Europe
1436 firms in this list, with a median first check of $642.5K. 340 of them lead rounds. Generated from verified public data and updated continuously.
Lightrock
LondonPre-Seed–Growth
16 people
Seroba Life Sciences
DublinSeed–Late Stage$540K – $7.6M
13 people
United Ventures
MilanSeed–Growth$54K – $5.4M
6 people
Fountain Healthcare Partners
DublinSeed–Series B$10.8M – $16.2M
8 people
NVM Private Equity LLP
Newcastle Upon TyneSeries A–Growth$6.5M – $20M
17 people
Quadrille Capital
ParisSeed–Late Stage
14 people
TIIN Capital
AmsterdamSeed–Growth$1.1M – $11M
8 people
Capital Cell
BarcelonaPre-Seed–Growth
Delta Partners
DublinPre-Seed–Series B$108K – $3.2M
6 people
TealTech Capital
MoscowSeed–Growth$1M
15 people
The Games Fund
LimassolPre-Seed–Series B
9 people
Atempo Growth
HeidelbergSeries A–Late Stage$3.3M – $49.5M
17 people
Hikma Ventures
LondonSeed–Late Stage$5M
14 people
Marathon Venture Capital
AthensSeed–Series B$250K – $1M
5 people
Heliad AG
Frankfurt am MainPre-Seed–Late Stage$5.4M – $16.2M
13 people
Coinvest Capital
VilniusPre-Seed–Growth$55K – $580K
9 people
Engelhardt Kaupp Kiefer & Co. Management GmbH
StuttgartSeries A–Late Stage$108K – $1.1M
11 people
Viola Credit
LondonPre-Seed–Late Stage$2M – $50M
14 people
20VC
LondonSeed–Growth$250K – $5M
4 people
Convent Capital Management AFF
AmsterdamSeries B–Growth
19 people
Adelie
ParisPre-Seed–Late Stage$2.2M – $10.8M
8 people
Kelvin Capital
GlasgowSeed–Late Stage
8 people
Kinnevik
StockholmSeed–Late Stage
2 people
Tamarind Hill
DublinPre-Seed–Series B$2M – $7M
7 people
Related lists
Investors & VC Firms in North America (13845)Investors & VC Firms in United States (12980)Seed Investors & VC Firms (10975)Series A Investors & VC Firms (8160)Pre-Seed Investors & VC Firms (5955)Seed Investors & VC Firms in North America (5705)Investors & VC Firms in Europe (5528)Seed Investors & VC Firms in United States (5128)Growth Investors & VC Firms (4870)Series A Investors & VC Firms in North America (4605)
Data sourced from public filings and firms' own websites — see our methodology.






























































































